中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2012年
3期
452-455
,共4页
冀保卫%陈谦学%刘宝辉%吴立权%田道锋%郭振涛%纪振刚
冀保衛%陳謙學%劉寶輝%吳立權%田道鋒%郭振濤%紀振剛
기보위%진겸학%류보휘%오립권%전도봉%곽진도%기진강
脑胶质瘤%树突状细胞%肿瘤疫苗%免疫疗法
腦膠質瘤%樹突狀細胞%腫瘤疫苗%免疫療法
뇌효질류%수돌상세포%종류역묘%면역요법
Glioma%Dendritic cells%Tumor vaccine%Immunotherapy
目的 应用热诱导凋亡U251细胞致敏树突状细胞,观察其诱导特异性细胞毒性T细胞的能力,探讨其对肿瘤细胞的杀伤机制.方法 应用改良Inaba法,从小鼠骨髓细胞中诱导出树突状细胞,应用电镜和流式细胞技术行表型鉴定,然后和经热诱导凋亡的胶质瘤细胞共培养获得树突状细胞疫苗,细胞计数试剂盒( CCK-8)检测疫苗在体外促T细胞增殖和杀伤肿瘤细胞作用,将疫苗经尾静脉注入荷瘤裸鼠体内,检测体内肿瘤生长抑制作用.结果 44℃孵育3h能有效诱导胶质瘤细胞凋亡,凋亡率达(40.10±1.08)%.负载凋亡细胞抗原的树突状细胞在体外能有效促进T细胞增殖,增加干扰素(IFN)-γ的分泌,并随效靶比增加,对胶质瘤细胞的杀伤率增大.体内注射疫苗4周后,治疗组肿瘤体积(301.704±21.659) mm3,空白对照组为(487.116 ±65.975) mm3,差异有统计学意义(P<0.01).结论 热诱导凋亡胶质瘤细胞致敏的树突状细胞能在体外有效促进T细胞增殖,诱导特异性细胞毒性T细胞杀伤胶质瘤细胞,有效抑制体内肿瘤生长.
目的 應用熱誘導凋亡U251細胞緻敏樹突狀細胞,觀察其誘導特異性細胞毒性T細胞的能力,探討其對腫瘤細胞的殺傷機製.方法 應用改良Inaba法,從小鼠骨髓細胞中誘導齣樹突狀細胞,應用電鏡和流式細胞技術行錶型鑒定,然後和經熱誘導凋亡的膠質瘤細胞共培養穫得樹突狀細胞疫苗,細胞計數試劑盒( CCK-8)檢測疫苗在體外促T細胞增殖和殺傷腫瘤細胞作用,將疫苗經尾靜脈註入荷瘤裸鼠體內,檢測體內腫瘤生長抑製作用.結果 44℃孵育3h能有效誘導膠質瘤細胞凋亡,凋亡率達(40.10±1.08)%.負載凋亡細胞抗原的樹突狀細胞在體外能有效促進T細胞增殖,增加榦擾素(IFN)-γ的分泌,併隨效靶比增加,對膠質瘤細胞的殺傷率增大.體內註射疫苗4週後,治療組腫瘤體積(301.704±21.659) mm3,空白對照組為(487.116 ±65.975) mm3,差異有統計學意義(P<0.01).結論 熱誘導凋亡膠質瘤細胞緻敏的樹突狀細胞能在體外有效促進T細胞增殖,誘導特異性細胞毒性T細胞殺傷膠質瘤細胞,有效抑製體內腫瘤生長.
목적 응용열유도조망U251세포치민수돌상세포,관찰기유도특이성세포독성T세포적능력,탐토기대종류세포적살상궤제.방법 응용개량Inaba법,종소서골수세포중유도출수돌상세포,응용전경화류식세포기술행표형감정,연후화경열유도조망적효질류세포공배양획득수돌상세포역묘,세포계수시제합( CCK-8)검측역묘재체외촉T세포증식화살상종류세포작용,장역묘경미정맥주입하류라서체내,검측체내종류생장억제작용.결과 44℃부육3h능유효유도효질류세포조망,조망솔체(40.10±1.08)%.부재조망세포항원적수돌상세포재체외능유효촉진T세포증식,증가간우소(IFN)-γ적분비,병수효파비증가,대효질류세포적살상솔증대.체내주사역묘4주후,치료조종류체적(301.704±21.659) mm3,공백대조조위(487.116 ±65.975) mm3,차이유통계학의의(P<0.01).결론 열유도조망효질류세포치민적수돌상세포능재체외유효촉진T세포증식,유도특이성세포독성T세포살상효질류세포,유효억제체내종류생장.
Objective To investigate the ability and mechanism of dendritic cells (DCs) inducing specific cytotoxicity T cells to kill giloma cells.Methods DCs were induced and cultured from the murine bone marrow cells by using modified Inaba method in vitro.The biological characteristics of DCs were detected by an electron microscope and flow cytometry.The DCs vaccine was obtained by mixing DCs with apoptotic glioma cells induced by heating treatment.The capacity of DCs vaccine promoting proliferation and killing glioma cells was tested by the method of cell counting kit-8 (CCK-8).DCs vaccine was injected into the tumor-bearing mice via the tail vein to examine the tumor growth inhibition in vivo.Results The flow cytometry confirmed that DCs vaccine highly expressed the typical surface markers CD11C,CD80,CD86 and MHC Ⅱ,and that the optimal thermal condition for inducing apoptosis of glioma cells was 44 ℃for 3 h with the maximum apoptosis rate being (40.10 ± 1.08)%.DCs loaded with apoptotic glioma cells antigen could effectively promote T cell proliferation,and increase the interferon-γ (IFN-γ) secretion.And increased effector/target ratio enhanced the cytotoxity activity.Four weeks after vaccine treatment,tumor size was (301.704 ±21.659) mm3 in treatment group,and (487.116 ±65.975) mm3 in blank control group (P <0.01 ).Conclusion DCs,sensitized by heating treatment apoptotic glioma cells,can effectively promote T cell proliferation and induce specific cytotoxic T cells to kill glioma cellsin vitro,and inhibit tumor growth in vivo.